drugset / Trial / NCT01183715
A Single Dose Study Of PF-05161704 In Healthy Volunteers
RandomizedCrossoverDouble-blindBasic science
Summary
The primary purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of single oral doses of PF-05161704 in healthy volunteers.
Timeline
- Start
- 2010-07
- Primary completion
- 2010-09
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-05161704 | Unknown | 1.5 mg | — |
| Subject | PF-05161704 | Unknown | 300 mg | — |